Dose-Response analyses of the carcinogenic effects of trichloroethylene in experimental animals

Environmental Health Perspectives

Volumn 108, Issue SUPPL. 2, 2000, Pages 343-358

  Rhomberg, Lorenz R ^a,b  

^a HARVARD CENTER FOR RISK ANALYSIS   (United States)

^b GRADIENT   (United States)

Author keywords

Carcinogenic potency; Cross species extrapolation; Dichloroacetic acid; Internal dose; Low dose extrapolation; Trichloroacetic acid; Trichloroethylene

Indexed keywords

CARCINOGEN; DICHLOROACETIC ACID; TRICHLOROACETIC ACID; TRICHLOROETHYLENE;

ANALYTIC METHOD; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOASSAY; CARCINOGENESIS; CONTROLLED STUDY; DOSE RESPONSE; EXPERIMENTAL ANIMAL; EXPOSURE; FEMALE; KIDNEY TUMOR; LIVER TUMOR; LUNG TUMOR; MALE; METABOLITE; MODEL; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; TARGET ORGAN; TOXICOKINETICS;

ANIMALIA;

EID: 0033945539     PISSN: 00916765     EISSN: None     Source Type: Journal    
DOI: 10.1289/ehp.00108s2343     Document Type: Article

References (45)

1. U.S. EPA. Health Assessment Document for Trichloroethylene, Final Report. EPA/600/8-82/006F. Washington, DC:U.S. Environmental Protection Agency, 1985.
2. U.S. EPA. Addendum to the Health Assessment Document for Trichloroethylene: Updated Carcinogenicity Assessment for Trichloroethylene. External Review Draft EPA/600/8-82/006FA. Washington, DC:U.S. Environmental Protection Agency, 1987
3. NTP. NTP Technical Report on the Toxicology and Carcinogenesis Studies of Trichloroethylene (CAS No. 79-01-6) in Four Strains of flats (ACI, August, Marshall, Osborne-Mendel) (Gavage Studies). NTP TR 273, Research Triangle Park, NC: National Toxicology Program, 1988.
4. 1 Mice (Gavage Studies). NTP TR 243. Research Triangle Park, NC:National Toxicology Program, 1990.
5. Allen BC, Fisher JW. Pharmacokinetic modeling of trichloroethylene and trichloroacetic acid in humans. Risk Anal 13:71-86 (1993).
6. Clewell HJ III, Gentry PR, Covington TR, Gearhart JM. Development of a physiologically based pharmacokinetic model of trichloroethylene and its metabolites for use in risk assessment. Environ Health Perspect 108(suppl 2):283-305 (2000).
7. Clewell HJ III, Gentry PR, Gearhart JM, Allen BC, Andersen ME. Considering pharmacokinetic and mechanistic information in cancer risk assessments for environmental contaminants: examples with vinyl chloride and trichloroethylene. Chemosphere 31:2561-2578 (1995).
8. Fisher JW, Allen BC. Evaluating the risk of liver cancer in humans exposed to trichloroethylene using physiological models. Risk Anal 13:87-95 (1993).
9. Fisher JW. Physiologically based pharmacokinetic models for trichloroethylene and its oxidative metabolites. Environ Health Perspect 108(suppl 2):265-273 (2000).
10. U.S. EPA. Proposed Guidelines for Carcinogen Risk Assessment. EPA/600/P-92/003C. Washington, DC:U.S Environmental Protection Agency, 1996.
11. 1 mice by dichloroacetate and trichloroacetate. Toxicology 63:341-359 (1990).
12. 1 mouse. Fundam Appl Toxicol 19:159-168 (1992).
13. 1 mouse. Fundam Appl Toxicol 16:337-347 (1991).
14. Herren-Freund SL, Pereira MA, Khoury MD, Olson G. The carcinogenicity of trichloroethylene and its metabolites, trichloroacetic acid and dichloroacetic acid, in mouse liver. Toxicol Appl Pharmacol 90:183-189 (1987).
15. 1 mice. Fundam Appl Toxicol 31:192-199 (1996).
16. Bull RJ. Mode of action of liver tumor induction by trichloroethylene and its metabolites, trichloroacetate and dichloroacetate. Environ Health Perspect 108(suppl 2):214-259 (2000).
17. Green T. The pulmonary toxicity and carcinogenicity of trichloroethylene: species differences and modes of action. Environ Health Perspect 108(suppl 2):261-264 (2000).
18. Lash LH, Fisher JW, Lipscomb J, Parker JC. Metabolism of trichloroethylene. Environ Health Perspect 108(suppl 2):177-200 (2000).
19. Lash LH, Parker JC, Siegel Scott C. Modes of action of trichloroethylene for kidney tumorigenesis. Environ Health Perspect 108(suppl 2):255-240 (2000).
20. Barton HA, Clewell HJ III. Evaluating noncancer effects of trichloroethylene: dosimetry, node of action, and risk assessment. Environ Health Perspect 108(suppl 2):323-334 (2000).
21. Henschler D, Romen W, Elasser HM, Reichert D, Eder E, Radwan Z. Carcinogenicity study of trichloroethylene by longterm inhalation in three animal species. Arch Toxikol 43:237-248 (1980).
22. 1 mice. Ann NY Acad Sci 534:316-342 (1986).
23. Howe RB, Crump KS. MULTI-WEIB: A Computer Program to Extrapolate Time to Tumor Animal Toxicity Data to Low Doses. Ruston, LA:Clement Associates, 1991.
24. Krewski D, Crump K, Farmer J, Gaylor D, Howe R, Portier C, Salsburg D, Sielken R, Van Ryzin J. A comparison of statistical methods for low dose extrapolation utilizing time-to-tumor data. Fundam Appl Toxicol 3:140-158 (1983).
25. Howe RB, Crump KS, Van Landingham C. GLOBAL86: A Computer Program to Extrapolate Quantal Animal Toxicity Data to Low Doses. Ruston, LA:K.S. Crump, 1986.
26. 3/4/day. Fed Reg 57:42152-42173 (1992).
27. Rhomberg LR. What constitutes 'dose'? (Definitions). In: Low-Dose Extrapolation of Cancer Risk: Issues and Perspectives (Olin S, Farland W, Park C, Rhomberg L, Scheuplein R, Starr T, Wilson J, eds). Washington, DC:ILSI Press, 1995.
28. Rhomberg LR. Use of quantitative modelling in methylene chloride risk assessment. Toxicology 102:95-114 (1995).
29. Bois FY. Statistical analysis of Clewell et al. PBPK model of trichloroethylene kinetics. Environ Health Perspect 108(suppl 2):307-316 (2000).
30. Bois FY. Statistical analysis of Fisher et al. PBPK model of trichloroethylene kinetics. Environ Health Perspect 108(suppl 2):275-282 (2000).
31. U.S. EPA. Methods for Derivation of Inhalation Reference Concentrations and Application of Inhalation Dosimetry. EPA/600/8-90/066F. Washington, DC:U.S. Environmental Protection Agency, 1994.
32. U.S. EPA. Technical Analysis of New Methods and Data Regarding Dichloromethane Hazard Assessment External Review Draft. EPA/600/8-87/029A. Washington, DC:U.S. Environmental Protection Agency, 1987.
33. U.S. EPA. Update to the Health Assessment Document and Addendum for Dichloromethane (Methylene Chloride): Pharmacokinetics, Mechanisms of Action, and Epidemiology. External Review Draft. EPA/600/8-87/030A. Washington, DC:U.S. Environmental Protection Agency, 1987.
34. Andersen ME, Clewell HJ III, Krishnan K. Tissue dosimetry, pharmacokinetic modeling, and interspecies scaling factors. Risk Anal 15:533-537 (1995).
35. Mordenti J. Man versus beast: pharmacokinetic scaling in mammals. J Pharmac Sci 75:1028-1040 (1986).
36. Travis CC, White RK, Ward RC. Interspecies extrapolation of pharmacokinetics. J Theoret Biol 142:285-304 (1990).
37. Fukuda K, Takemoto K, Tsuruta H. Inhalation carcinogenicity of trichloroethylene in mice and rats. Ind Health 21:243-254 (1983).
38. Wartenberg D, Reyner D, Scott CS. Trichloroethylene and cancer: epidemiologic evidence. Environ Health Perspect 108(suppl 2):161-176 (2000).
39. Moore M, Harrington-Brock K. Mutagenicity of trichloroethylene and its metabolites: implications for the risk assessment of trichloroethylene. Environ Health Perspect 108(suppl 2):215-2230 (2000).
40. NCI. Carcinogenesis Bioassay of Trichloroethylene. CAS No. 79-01-6 NIH-77-813. Bethesda, MD:National Cancer Institute, 1976.
41. Andersen ME, Clewell HJ III, Gargas ML, Smith FA, Reitz RH. Physiologically based pharmacokinetics and the risk assessment process for methylene chloride. Toxicol Appl Pharmacol 87:185-205 (1987).
42. Smith AE, Gray GM, Evans JS. The ability of predicted internal dose measures to reconcile tumor bioassay data for chloroform. Regul Toxicol Pharmacol 21:339-351 (1995).
43. Bell Z, Olson K, Benya T. Final Report of Audit Findings of the Manufacturing Chemists Association (MCA): Administered Trichloroethylene (TCE) Chronic Inhalation Study at Industrial Bio-Test Laboratorie, Decatur, IL:Bio-Test Laboratories, 1978.
44. Odum J, Foster JR, Green T. A mechanism for the development of Clara cell lesions in the mouse lung after exposure to trichloroethylene. Chem-Biol Interact 83:135-153 (1992).
45. Henschler D, Vamvakas S, Lammert M, Dekant W, Kraus B, Thomas B, Ulm K. Increased incidence of renal cell tumors in a cohort of cardboard workers exposed to trichloroethene. Arch Toxikol 69:291-299 (1995).